Ovarian cancer is a malignant tumor that begins in the ovaries—the female reproductive glands responsible for producing eggs and hormones. Often referred to as the "silent killer" due to its subtle symptoms in the early stages, ovarian cancer is most commonly diagnosed at an advanced stage. Surgery plays a pivotal role in the treatment of ovarian cancer and is often the first step in a multi-modality approach that may include chemotherapy and targeted therapy.
India has become a preferred destination for ovarian cancer surgery due to its expert gynecologic oncology teams, internationally accredited hospitals, and cost-effective treatment packages. Indian hospitals follow evidence-based surgical protocols, offering both curative and fertility-sparing options depending on the stage, type, and age of the patient. With high-end operating rooms, robotic systems, and personalized care pathways, India delivers quality outcomes with global standards.
Indian oncology centers are fully equipped to manage all types and subtypes of ovarian cancer:
Epithelial Ovarian Cancer (most common type)
Germ Cell Tumors (often affecting younger women)
Stromal Tumors (originating in hormone-producing cells)
Borderline Ovarian Tumors (low malignant potential)
Metastatic Ovarian Cancer (cancer spread from or to ovaries)
Each type requires a tailored surgical and medical approach, determined through accurate staging and biopsy.
Precise diagnosis is crucial before surgery. The following tests are typically conducted at Indian hospitals:
Pelvic Examination and Transvaginal Ultrasound
CA-125 Blood Test (tumor marker)
CT/MRI/PET-CT Scans for staging and spread
Laparoscopy or Surgical Biopsy to confirm diagnosis
Histopathology and Immunohistochemistry for subtype classification
Genetic Testing (e.g., BRCA1/2) to determine hereditary risk
These assessments help oncologists decide the appropriate surgical route and whether neoadjuvant chemotherapy is needed before surgery.
India offers a wide spectrum of surgical procedures, from conservative approaches for early-stage cancers to aggressive debulking for advanced disease, all conducted by highly trained gynecologic oncologists.
This is the most commonly performed surgery, involving removal of the uterus, both ovaries, and fallopian tubes. It is ideal for postmenopausal or advanced-stage patients.
In early-stage cancer, especially in younger women, Indian specialists may preserve one ovary and the uterus to maintain fertility, while still ensuring cancer control.
For advanced ovarian cancer, surgeons aim to remove as much of the tumor burden as possible. This includes removal of the omentum, lymph nodes, peritoneum, and visible tumor deposits.
Minimally invasive techniques are increasingly used for early-stage ovarian cancers or diagnostic procedures, allowing shorter hospital stays and faster recovery.
Some centers in India offer this advanced procedure post-debulking surgery. It involves circulating heated chemotherapy directly in the abdominal cavity to destroy microscopic cancer cells.
You may be eligible for surgery in India if you:
Have a confirmed diagnosis of ovarian cancer (via biopsy or imaging)
Are medically fit for surgery (evaluated by oncologists and anesthetists)
Need second-line surgical intervention after chemotherapy
Seek fertility preservation options for early-stage disease
Desire affordable and timely surgery at international-standard hospitals
Medical reports, blood tests, and imaging results are reviewed by Indian specialists before finalizing a treatment plan.
|
Procedure |
Hospital Stay |
Full Recovery |
|
TAH-BSO (Standard Surgery) |
4–6 days |
3–4 weeks |
|
Cytoreductive Debulking Surgery |
7–10 days |
4–6 weeks |
|
HIPEC Procedure |
10–14 days |
6–8 weeks |
|
Laparoscopic Surgery |
2–3 days |
1–2 weeks |
Post-surgical follow-up often includes chemotherapy, depending on pathology findings. Nutritional support, physical rehabilitation, and psychological counseling are part of the recovery process.
|
Surgery Type |
Estimated Cost (INR) |
Estimated Cost (USD) |
|
TAH-BSO |
₹2,00,000 – ₹3,50,000 |
$2,400 – $4,200 |
|
Debulking Surgery + HIPEC |
₹5,00,000 – ₹9,00,000 |
$6,000 – $10,800 |
|
Laparoscopic/Fertility-Sparing |
₹2,50,000 – ₹4,00,000 |
$3,000 – $4,800 |
|
Post-Surgical Chemotherapy (6 cycles) |
₹1,50,000 – ₹3,00,000 |
$1,800 – $3,600 |
Patients typically save 60–70% on surgery and follow-up care compared to costs in Western countries.
Experienced Gynecologic Oncologists trained in global centers
Advanced Surgical & Robotic Facilities at top-tier hospitals
Affordable, Transparent Pricing with no compromise on quality
Multidisciplinary Support including nutritionists and counselors
JCI- and NABH-accredited Hospitals with modern ICUs
Short Wait Times and quick access to operating theaters
Medical Tourism Services including visa help, lodging, and translators
Early-stage ovarian cancer (Stage I): 90–95% 5-year survival rate with surgery
Advanced-stage with optimal debulking: 65–75% survival with combined therapy
Fertility-sparing surgery: High success with preserved reproductive function
HIPEC following debulking: Improved outcomes in select advanced cases
Success depends on early diagnosis, tumor grade, patient health, and access to timely surgery and chemotherapy.
India has emerged as a trusted hub for ovarian cancer surgery, offering globally comparable surgical care at significantly lower costs. With highly skilled gynecologic oncologists, modern technology, and personalized support, Indian hospitals ensure that women from around the world receive timely, effective, and compassionate treatment. Whether it’s a fertility-sparing procedure or complex cytoreductive surgery, patients can expect excellence in every aspect of care, making India a wise and reassuring choice for ovarian cancer treatment.
1. Is surgery the first step in treating ovarian cancer?
Yes, in most cases, surgery is the first line of treatment unless neoadjuvant chemotherapy is required to shrink tumors before operation.
2. Can I preserve my fertility with ovarian cancer surgery in India?
Yes, fertility-preserving options are available for eligible early-stage patients, especially in younger women.
3. How soon can I travel for surgery in India?
Once your reports are reviewed, Indian hospitals can schedule surgery within a few days and assist with fast visa processing.
4. Are Indian hospitals safe and internationally accredited?
Yes, leading hospitals are NABH and JCI accredited and follow global surgical and infection-control protocols.
5. What are the chances of recurrence after surgery?
Recurrence depends on cancer stage and type. Regular follow-ups and adjuvant therapy help reduce the risk.
6. Is robotic surgery available for ovarian cancer?
Yes, robotic and laparoscopic surgeries are offered at select Indian hospitals for early-stage cases.
7. What’s included in the treatment package?
Typically includes surgery, hospital stay, medications, pathology, and immediate follow-up. Additional chemotherapy is costed separately.
8. How do I get started with treatment in India?
You can share your medical records for review. Once evaluated, hospitals send a treatment plan, cost estimate, and help arrange travel.